Kadant
KAI
257.86
-5.80
-2.20%
Kadant
US · KAI
#2436 by market cap
Listed 1970
257.86
-5.80
-2.20%
Live - 5344 symbols - heartbeat 367s ago
· 2026-10-07 19:54
After-hours
257.86
0.00%
- Market cap
- 3.05B
- P/E (TTM)i
- 27.73
- P/Bi
- 2.98
- EPSi
- 8.65
- Div yieldi
- 0.54%
- 52W posi
- 13%
Reader sentiment
Are you bullish or bearish on KAI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.45, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -0.11% YoY
Margins
- Gross margin
- 45.21%
- Operating margin
- 15.07%
- Net margin
- 9.69%
Key ratios & quality
- Enterprise valuei
- 3.30B
- Altman Z-Scorei
- 4.45
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 633.79M | 704.64M | 635.03M | 786.58M | 904.74M | 957.67M | 1.05B | 1.05B |
| Gross profit | 278.28M | 293.76M | 277.31M | 337.37M | 389.56M | 416.31M | 466.15M | 475.73M |
| Selling & admin expenses | 177.41M | 192.53M | 181.91M | 208.79M | 224.41M | 236.26M | 279.92M | 301.86M |
| Research & development | 10.55M | 10.88M | 11.30M | 11.40M | 12.72M | 13.56M | 14.32M | 15.26M |
| Operating profit | 90.32M | 90.35M | 84.10M | 117.18M | 152.43M | 166.48M | 171.91M | 158.60M |
| Pretax profit | 79.53M | 68.92M | 73.69M | 112.05M | 165.64M | 159.02M | 153.07M | 143.59M |
| Tax | 18.48M | 16.36M | 17.95M | 27.17M | 43.91M | 42.21M | 40.52M | 39.90M |
| Net profit | 61.05M | 52.56M | 55.74M | 84.88M | 121.73M | 116.81M | 112.55M | 103.68M |
| Basic EPS | 5 | 5 | 5 | 7 | 10 | 10 | 10 | 9 |
| Diluted EPS | 5.30 | 4.54 | 4.77 | 7.21 | 10.35 | 9.90 | 9.48 | 8.65 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 239.21M | 255.27M | 271.57M | 286.20M | 281.51M | 312.88M |
| Gross profit | 110.33M | 117.04M | 122.66M | 125.70M | 126.70M | 137.01M |
| Selling & admin expenses | 71.22M | 73.94M | 75.84M | 80.86M | 82.54M | 81.64M |
| Research & development | 3.52M | 3.72M | 3.92M | 4.10M | 4.06M | 4.48M |
| Operating profit | 35.59M | 39.38M | 42.62M | 41.02M | 40.11M | 50.88M |
| Pretax profit | 32.27M | 36.46M | 39.88M | 34.98M | 35.96M | 46.03M |
| Tax | 7.83M | 9.82M | 11.77M | 10.49M | 10.14M | 13.18M |
| Net profit | 24.44M | 26.64M | 28.12M | 24.49M | 25.82M | 32.85M |
| Basic EPS | 2 | 2 | 2 | 2 | 2 | 3 |
| Diluted EPS | 2.04 | 2.22 | 2.35 | 2.04 | 2.16 | 2.75 |
Balance sheet
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 252.76M | 297.58M | 289.82M | 383.88M | 415.41M | 440.18M | 442.33M | 541.93M |
| Cash & ST investments | 45.83M | 66.79M | 65.68M | 91.19M | 76.37M | 103.83M | 94.66M | 119.55M |
| Inventory | 86.37M | 102.72M | 106.81M | 134.36M | 163.67M | 152.68M | 146.09M | 206.85M |
| Total assets | 725.75M | 939.39M | 927.57M | 1.13B | 1.15B | 1.18B | 1.43B | 1.71B |
| Total current liabilities | 128.99M | 146.17M | 134.69M | 221.50M | 213.46M | 214.41M | 191.57M | 228.17M |
| Short-term debt | 1.67M | 2.85M | 1.47M | 5.36M | 3.82M | 3.21M | 3.38M | 3.13M |
| Long-term debt | 174.15M | 298.17M | 232.00M | 264.16M | 197.34M | 107.67M | 285.15M | 371.37M |
| Total liabilities | 351,178,000.00 | 512,308,000.00 | 430,666,000.00 | 566,596,000.00 | 494,310,000.00 | 399,425,000.00 | 572,217,000.00 | 721,111,000.00 |
| Total equity | 374.57M | 427.08M | 496.91M | 565.62M | 655.57M | 776.24M | 858.13M | 991.07M |
| Retained earnings | 393.58M | 435.25M | 479.40M | 551.85M | 660.64M | 763.13M | 859.69M | 945.64M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 446.73M | 474.69M | 519.96M | 541.93M | 562.64M | 580.82M |
| Cash & ST investments | 91.68M | 95.32M | 124.49M | 119.55M | 117.03M | 134.53M |
| Inventory | 153.54M | 168.59M | 179.71M | 206.85M | 214.83M | 216.46M |
| Total assets | 1.44B | 1.48B | 1.53B | 1.71B | 1.71B | 1.89B |
| Total current liabilities | 180.62M | 199.79M | 212.52M | 228.17M | 227.43M | 224.16M |
| Short-term debt | 3.38M | 3.26M | 3.39M | 3.13M | 3.16M | 3.18M |
| Long-term debt | 273.50M | 245.67M | 254.62M | 371.37M | 360.20M | 507.46M |
| Total liabilities | 548,869,000.00 | 547,221,000.00 | 570,727,000.00 | 721,111,000.00 | 708,503,000.00 | 855,547,000.00 |
| Total equity | 886.57M | 937.29M | 961.51M | 991.07M | 1.01B | 1.03B |
| Retained earnings | 879.75M | 901.91M | 925.62M | 945.64M | 966.90M | 995.12M |
Cash flow
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 62.99M | 97.41M | 92.88M | 162.42M | 102.63M | 165.55M | 155.27M | 171.33M |
| Depreciation & amortization | 23.57M | 32.39M | 31.33M | 34.30M | 34.94M | 33.30M | 49.59M | 51.22M |
| Free cash flow | 46.43M | 87.46M | 85.29M | 149.65M | 74.43M | 133.70M | 134.26M | 154.28M |
| Dividends paid | -9.64M | -10.20M | -10.90M | -11.46M | -12.00M | -13.22M | -14.67M | -15.78M |
| Stock buybacks / issuance | 813.00K | 5.18M | 3.21M | 1.89M | 1.38M | 0 | 1.61M | 4.57M |
| Ending cash balance | 46.12M | 68.27M | 66.64M | 94.16M | 79.73M | 106.45M | 95.95M | 122.68M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 22.84M | 40.48M | 47.25M | 60.76M | 21.92M | 53.51M |
| Depreciation & amortization | 12.01M | 12.07M | 12.40M | 14.74M | 14.65M | 15.54M |
| Free cash flow | 19.00M | 36.51M | 44.06M | 54.71M | 18.66M | 42.56M |
| Dividends paid | -3.76M | -4.00M | -4.00M | -4.01M | -4.01M | -4.25M |
| Stock buybacks / issuance | 2.10M | 0 | 0 | 2.47M | 0 | 0 |
| Ending cash balance | 93.81M | 97.19M | 126.91M | 122.68M | 119.82M | 137.62M |
Returns & efficiency
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 17.16 | 13.04 | 11.99 | 15.87 | 19.86 | 16.26 | 13.77 | 11.16 |
| ROA %i | 8.13 | 6.25 | 5.91 | 8.16 | 10.60 | 9.98 | 8.56 | 6.49 |
| ROIC %i | 11.68 | 9.66 | 8.34 | 11.20 | 14.81 | 13.90 | 12.37 | 8.98 |
| 5-year avg ROE %i | 12.53 | 12.99 | 12.80 | 13.64 | 15.58 | 15.40 | 15.55 | 15.38 |
| EBIT margin %i | 13.66 | 11.59 | 12.77 | 14.86 | 19.02 | 17.48 | 16.43 | 15.13 |
| FCF / sales %i | 7.33 | 12.41 | 13.43 | 19.03 | 8.23 | 13.96 | 12.75 | 14.66 |
| Current ratioi | 1.96 | 2.04 | 2.15 | 1.73 | 1.95 | 2.05 | 2.31 | 2.38 |
| Quick ratioi | 1.20 | 1.20 | 1.22 | 0.98 | 1.04 | 1.15 | 1.33 | 1.25 |
| Debt / assetsi | 24.23 | 32.04 | 25.17 | 23.80 | 17.49 | 9.43 | 20.17 | 21.87 |
| LT debt / equityi | 46.69 | 70.04 | 46.83 | 46.84 | 30.18 | 13.92 | 33.66 | 37.90 |
| Interest coveragei | 12.31 | 6.40 | 10.93 | 24.24 | 26.57 | 19.93 | 8.64 | 10.22 |
| Revenue CAGR (3Y) %i | 17.56 | 19.38 | 7.23 | 7.46 | 8.69 | 14.68 | 10.23 | 5.16 |
| Net income CAGR (3Y) %i | 20.66 | 17.52 | 21.08 | 11.63 | 32.43 | 28.12 | 9.91 | -5.53 |
| FCF CAGR (3Y) %i | 9.99 | 24.61 | 21.22 | 47.72 | -5.24 | 16.16 | -3.55 | 27.51 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 13.38 | 12.21 | 11.32 | 11.16 | 11.05 | 11.26 |
| ROA %i | 7.80 | 7.20 | 6.75 | 6.49 | 6.57 | 6.50 |
| ROIC %i | 11.02 | 10.07 | 9.35 | 8.98 | 9.06 | 8.96 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 16.45 | 15.89 | 15.26 | 15.13 | 14.94 | 15.19 |
| FCF / sales %i | 13.10 | 14.66 | 14.25 | 14.66 | 14.06 | 13.89 |
| Current ratioi | 2.47 | 2.38 | 2.45 | 2.38 | 2.47 | 2.59 |
| Quick ratioi | 1.38 | 1.30 | 1.38 | 1.25 | 1.30 | 1.39 |
| Debt / assetsi | 19.29 | 16.77 | 16.84 | 21.87 | 21.19 | 27.03 |
| LT debt / equityi | 31.22 | 26.53 | 26.81 | 37.90 | 36.18 | 49.61 |
| Interest coveragei | 8.95 | 9.40 | 10.50 | 10.22 | 10.07 | 9.61 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Industrial Processing is the largest reported line at 45.96% of revenue, across 3 reported segments.
- Flow Control follows at 32.06%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Industrial Processing45.96%
Flow Control32.06%
Material Handling21.98%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.